Amrize Ltd (NYSE: AMRZ) Not A Good Play Anymore?

Amrize Ltd (AMRZ) concluded trading on Thursday at a closing price of $50.98, with 3.79 million shares of worth about $193.11 million changed hands on the day. July 10, 2025 the price saw a loss of about -0.60%. Currently the company’s common shares owned by public are about 552.74M shares, out of which, 494.11M shares are available for trading.

Over the period of past 52 weeks, stock dropped to lowest price of $48.01 but also hit the highest price of $56.29 during that period. The average intraday trading volume for Amrize Ltd shares is 4.62 million. The stock is currently trading 1.16% above its 20-day simple moving average (SMA20), while that difference is up 1.16% for SMA50 and it goes to 1.16% higher than SMA200.

Amrize Ltd (NYSE: AMRZ) currently have 552.74M outstanding shares and institutions hold larger chunk of about 0.14% of that.

The stock has a current market capitalization of $28.18B. It has Quick Ratio of 1.22 while making debt-to-equity ratio of 0.98. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for AMRZ, volatility over the week remained 1.80%.

Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Bernstein on July 10, 2025 offering an Outperform rating for the stock and assigned a target price of $62 to it. Coverage by Goldman stated Amrize Ltd (AMRZ) stock as a Neutral in their note to investors on July 01, 2025, suggesting a price target of $57 for the stock. Stock get a Buy rating from Berenberg on June 30, 2025.

Related Posts

Life Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.